OS
Oh Stefan K.L.
首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Oh Stefan K.L., 首席执行官. Director active across 2 companies, notably Griffin-American Healthcare REIT III, Inc.. In total, 19 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €118k. History available since 3 October 2022. The latest transaction was disclosed on 6 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Oh Stefan K.L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
1,621 股@ US$48.0914.3% 占其流量Common StockSEC:0001193125-26-147749:1
3,185 股Common StockSEC:0001193125-26-147749:0
9,151 股Common StockSEC:0001193125-26-129185:0
6,370 股Common StockSEC:0001193125-26-108438:0
10,166 股@ US$48.7741.6% 占其流量Common StockSEC:0001193125-26-046635:0
3,860 股@ US$36.1020.1% 占其流量Common StockSEC:0001518484-25-000012:0
3,185 股Common StockSEC:0001518484-25-000008:0
9,151 股Common StockSEC:0001518484-25-000006:0
1,904 股Common StockSEC:0001518484-25-000004:0
6,796 股@ US$29.3047.9% 占其流量Common StockSEC:0001518484-25-000002:0
6,169 股@ US$25.0734.7% 占其流量Common StockSEC:0001518484-24-000012:0
787 股@ US$26.104.6% 占其流量Common StockSEC:0001518484-24-000010:0
26,207 股Class T Common StockSEC:0001518484-24-000008:0
3,184 股Class T Common StockSEC:0001518484-24-000006:0
74,074 股0Common StockSEC:0001518484-24-000002:0
762 股@ US$31.405.7% 占其流量Class T Common StockSEC:0001518484-23-000004:0
3,047 股@ US$9.297.1% 占其流量Class T Common StockSEC:0001518484-22-000001:0
1,598 股Class I Common StockSEC:0001518484-21-000004:0
16,667 股Common StockSEC:0001518484-21-000002:0
About Oh Stefan K.L.
Oh Stefan K.L. is Directeur Général and also serves as Chief Investment Officer at American Healthcare REIT, Inc. and E.V.P. - Acquisitions at Griffin-American Healthcare REIT III, Inc. He has 19 filings in total, and across the recent sample of 19 filings the activity is mainly option exercises, with sales amounting to EUR 118218 between 2021-10-04 and 2026-04-08.